Commercial Product Portfolio
DFB owns a portfolio of commercial products that are licensed to sales and marketing partners globally.
Aldahol® – The result of a groundbreaking scientific discovery that isopropanol greatly enhances the bactericidal, viricidal, and fungicidal activity of glutaraldehyde, Aldahol provides fast-acting, room temperature, high-level disinfection of surgical and related equipment.
Surgicept® – A waterless surgical hand antiseptic that provides rapid and broad spectrum anti-microbial activity.
Triseptin® – An alcohol-based, water-aided surgical hand scrub that kills and removes microorganisms on the skin.
DFB Shanghai. In conjunction with our partner in China, we are building a world-class manufacturing facility that will bring our infection control portfolio to the Chinese market.
Docetaxel Injection USP – An injectable oncology product with ANDA approval in the US as a generic equivalent to Taxotere® (Aventis Pharma SA) and available for license or sale both within and outside the US.